학술논문
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer
Document Type
Article
Author
Source
In: Cancer . (Cancer, 1 April 2024, 130(7):1061-1071)
Subject
Language
English
ISSN
10970142
0008543X
0008543X